153 related articles for article (PubMed ID: 9726628)
1. The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats.
Jia L; Blantz RC
Eur J Pharmacol; 1998 Jul; 354(1):33-41. PubMed ID: 9726628
[TBL] [Abstract][Full Text] [Related]
2. Acute and subacute toxicity and efficacy of S-nitrosylated captopril, an ACE inhibitor possessing nitric oxide activities.
Jia L; Pei R; Lin M; Yang X
Food Chem Toxicol; 2001 Dec; 39(12):1135-43. PubMed ID: 11696388
[TBL] [Abstract][Full Text] [Related]
3. [A design of a novel compound S-nitrosocaptopril possessing the capacities of both angiotensin converting enzyme inhibitors and NO donors].
Jia L
Sheng Li Ke Xue Jin Zhan; 1999 Jan; 30(1):53-6. PubMed ID: 12532851
[No Abstract] [Full Text] [Related]
4. Antiangiogenic effects of S-nitrosocaptopril crystals as a nitric oxide donor.
Jia L; Wu CC; Guo W; Young X
Eur J Pharmacol; 2000 Mar; 391(1-2):137-44. PubMed ID: 10720645
[TBL] [Abstract][Full Text] [Related]
5. Effects of verapamil alone and with captopril on blood pressure and bilateral renal function in Goldblatt hypertensive rats.
Huang WC
Clin Sci (Lond); 1986 May; 70(5):453-60. PubMed ID: 3516532
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertension.
Ichikawa I; Ferrone RA; Duchin KL; Manning M; Dzau VJ; Brenner BM
Circ Res; 1983 Nov; 53(5):592-602. PubMed ID: 6194914
[TBL] [Abstract][Full Text] [Related]
7. Glomerular hemodynamics of the clipped kidney: effects of captopril and diltiazem.
Frei U; Schindler R; Matthies C; Koch KM
J Pharmacol Exp Ther; 1992 Dec; 263(3):938-42. PubMed ID: 1469650
[TBL] [Abstract][Full Text] [Related]
8. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T
Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779
[TBL] [Abstract][Full Text] [Related]
9. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo.
Brouwers S; Smolders I; Massie A; Dupont AG
Hypertension; 2013 Nov; 62(5):920-6. PubMed ID: 24041944
[TBL] [Abstract][Full Text] [Related]
11. Physicochemistry, pharmacokinetics, and pharmacodynamics of S-nitrosocaptopril crystals, a new nitric oxide donor.
Jia L; Young X; Guo W
J Pharm Sci; 1999 Oct; 88(10):981-6. PubMed ID: 10514343
[TBL] [Abstract][Full Text] [Related]
12. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
[TBL] [Abstract][Full Text] [Related]
13. Captopril and S-nitrosocaptopril as potent radiosensitizers: Comparative study and underlying mechanisms.
Jordan BF; Peeterbroeck J; Karroum O; Diepart C; Magat J; Grégoire V; Gallez B
Cancer Lett; 2010 Jul; 293(2):213-9. PubMed ID: 20144849
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early Goldblatt hypertensive rats.
Palm F; Connors SG; Mendonca M; Welch WJ; Wilcox CS
Hypertension; 2008 Feb; 51(2):345-51. PubMed ID: 18158356
[TBL] [Abstract][Full Text] [Related]
15. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II and renal functional reserve in rats with Goldblatt hypertension.
De Nicola L; Keiser JA; Blantz RC; Gabbai FB
Hypertension; 1992 Jun; 19(6 Pt 2):790-4. PubMed ID: 1592482
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive and renal effects of cilazapril and their reversal by angiotensin in renovascular hypertensive rats.
Ding YA; Chang ST; Shieh SM; Huang WC
Clin Sci (Lond); 1988 Apr; 74(4):365-72. PubMed ID: 2965632
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of S-nitrosocaptopril on vasomotor tone.
Lin MJ; Yang XP; Wang J; Jia BJ; Jia L
Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):485-8. PubMed ID: 10375817
[TBL] [Abstract][Full Text] [Related]
19. Importance of the renin-angiotensin system in the generation of kidney failure in renovascular hypertension.
Abdi A; Johns EJ
J Hypertens; 1996 Sep; 14(9):1131-7. PubMed ID: 8986915
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
